Original Article

The Role of Intranasal Corticosteroid Therapy on Pediatric Adenoidal Hypertrophy: A Randomized Clinical Trial Study

Abstract

 Background:Adenoidal hypertrophy (AH) is a common disorder in pediatric population with severe complications due to nasal air way obstruction. Adenoidectomy is a choice treatment for children with severe symptoms due to AH, however; it is accompanied with several side effects such as complication of surgery and emotional distress. We evaluated the efficacy of intranasal corticosteroid (Fluticasone) therapy on size and symptoms of Adenoid Hypertrophy.

Methods: In this clinical trial 45children with AH (2-14 years old) were enrolled. All of them underwent 8 weeks course of intranasal Fluticasone therapy and their symptoms before and after treatment were scored and also compared by questionnaires. They were divided into Atopic and non- Atopic groups and these two groups were compared with each other after treatment according to their response to therapy.

Results: After 8 weeks treatment with intra nasal fluticasone, improvement in all symptoms score of AH including (Snoring , Sleep Apnea ,Mouth breathing and Nasal congestion)  was statistically significant(p=0.000). Significant improvement after treatment was observed in atopic patients and 92% of them (36 of 39) showed decrease clinical symptom of AH however this number in non-atopic patients was 50% (p value =0.024).

 Conclusion: Our study demonstrates that an 8 weeks treatment with intranasal corticosteroid (Fluticasone) is associated with decrease in size of AH and all symptoms of obstruction. So intranasal corticosteroid therapy can prevent of adenoidectomy especially in atopic patients.

1.Berlucchi M, Salsa D, Valetti L, Parrinello G, Nicoli P. The role of mometasone frosted aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group. Pediatric .2007;119:1392-97.
2. Wiley J, Sons A/S. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. PAL. 2010; 21:1095-106.
3. Charles D, Bluestone, Gerald B, Healy, Jeffery P, Simons. Pediatric Otolaryngology.5th ed.st .2015.1212p.
4. Gozal L.kh, Seperol L. D, Dayyat E, kim J, Goldman J. L, Snow A, et al. Corticosteroids suppress in vitro tonsilar proliferation in children with obstructive sleep apnea. Eur Respir J.2009; 33:1077-84.
5. Friedman B.C, Goldman R.D. Anti-inflammatory therapy for obstruction sleep apnea in children. CFP. 2011;57:891-98.
6. Jung YG, Kim HY, Min Jr, Dhong HJ, Chung SK.Role of intranasal topical steroid in pediatric sleep disordered breathing and influence of allergy, sinusitis and obesity on treatment outcome. CEO. 2011;4:27-32.
7.Madrzynsk M, Mazurek H, Zawisa E.Allergic tonsillitis :myth or reality. Postepyhig Med dosw. 2005;59: 450-56.
8. Zhang L, Mendoza RA, Cesar JA, Chdha Nk. Topical steroids for nasal airway obstruction in children with moderately to severely enlarged adenoids. The Cochrane library. 2008;3;10
9. Saleh M, Mohammad Baqher R. Parisa O. Assessment of intranasal steroid effect in management of adenoid hypertrophy in children 2-11 years old. J Pharm Pharmacol. 2014; 2:211-17.
10. Alisha C, Avtar L,Karen C,Arunabha C,Sunil G . Systematic review and meta- analysis of randomized controlled trial on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015; 79:1599-1608.
11. Tamer S. Role of intranasal steroid in the prevention of recurrent nasal symptom after adenoidectomy. Int J Otolaryngol. 2013; 2013:15
12. Fevzi S, Mustafa E, Osman D. Are nasal steroids effective in children with adenoid hypertrophy? Eu R J.2019; 5:311-18.
13. Ciprandi G, Varricchio A, Capasso M. Intranasal flunisolide treatment in children with adenoidal hypertrophy. Int J Immunopathol Pharmacol. 2007;20:833-36.
14.Sakarya E, Bayar N, Sakalar E. Use of intranasal corticosteroids in adenotonsillar hypertrophy. JLO. 2017; 131:384-90.
15.Mohammad H, Hazama M, Nik mohd Y. Mometasone intra nasals pray is effective in reducing symptoms and adenoid size in children and adolescent with adenoid hypertrophy. Acta Otorhinolaryngol . 2020;71:147-153.
16.Berlucchi M, Valenti L, Parrinello G, Nicolai P. Long term follow up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. Int J Pediatr Otorhinolaryngol . 2008;72(8)1171-75.
17.Damirhan H, Veyseller B.Medical treatment of adenoid hypertrophy with fluticasone propionate nasal drops. Int J Pediatr Otorhinolaryngol. 2010;74: 773-76.
18.Berlucchi M, Sessa M. Can adenoidal hypertrophy be treated with intranasal steroids? Rev. Recent Clin Trials. 2010;5 (2):123-27.
19. Vikram K, Vibhor B, Arshad M. Steroid nasal spray versus curettage adenoidectomy in school children. J Otolaryngology –ENT Rs. 2019 ;8 (5):502-6
20. Bitar MA, Mahmoud L, Nassar J, Dana R. Exploring the characteristics of children with obstructive adenoid responding to mometasone furate monohydrate: Preliminary results. Eur arch otorhinolaryngol. 2013;270:931-37.
21.Yasser M, Samer A, Mohamed S. Efficacy of intranasal corticosteroids in improving nasal airway obstruction in children with symptomatic adenoidal hypertrophy: Meta-Analysis and systematic review. EJO. 2019;35:30-36.
Files
IssueVol 4, No 3 (2021) QRcode
SectionOriginal Article
DOI https://doi.org/10.18502/igj.v4i3.12116
Keywords
Adenoid Hypertrophy Intranasal Corticosteroids Adenoidectomy Fluticasone
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sadeghi-Shabestari M, Naderpoor M, Farzipour S, Dastranji A. The Role of Intranasal Corticosteroid Therapy on Pediatric Adenoidal Hypertrophy: A Randomized Clinical Trial Study. Immunol Genet J. 2021;4(3):161-165.